title: Nominations of Difficult to Compound Drugs TO THE U.S. FOOD AND DRUG ADMINISTRATION--PHARMACY COMPOUNDING ADVISORY COMMITTEE: PART 1.
abstract: This is part 1 of a 2-part article on the topic of nominations of Difficult to Compound Drugs to the FDA-PCAC. Part 2, which will discuss the evaluation procedure for determining which drugs are demonstrably difficult to compound, will be published in the International Journal of Pharmaceutical Compounding's November-December 2015 issue.
authors.forename: Loyd V
authors.initials: LV
authors.lastname: Allen
mesh_terms: D026683:Advisory Committees; D004339:Drug Compounding; D014481:United States; D014486:United States Food and Drug Administration